Paper Details
- Home
- Paper Details
Detrimental effects of niacin/laropiprant on microvascular reactivity and red cell deformability in patients with elevated lipoprotein(a) levels.
Author: AbbateRosanna, BandinelliBrunella, CioniGabriele, CostanzoMaria, D'AlessandriGiovanna, FatiniCinzia, LiottaAlessandrello Agatina, ManniniLucia, MarcucciRossella
Original Abstract of the Article :
Several studies have found a beneficial effect of nicotinic acid on lipid profile, but there remains a limitation in the clinical use of nicotinic acid due to its side effects. In this study, 46 (F/M = 22/24, age = 58.74 ± 10.02 years) patients with Lp(a) ≥500 mg/L and with a previous arterial throm...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s11239-015-1256-9
データ提供:米国国立医学図書館(NLM)
Impact of Niacin/Laropiprant on Microvascular Reactivity and Red Blood Cell Deformability in Patients with Elevated Lipoprotein(a) Levels
This study delves into the realm of [cardiovascular health], specifically addressing the intriguing relationship between niacin/laropiprant and microvascular reactivity, red blood cell deformability, and elevated lipoprotein(a) levels. The researchers employed a [clinical trial] design to investigate the impact of this treatment regimen on patients with a history of arterial thrombotic events and elevated lipoprotein(a) levels. Their findings paint a complex picture, suggesting a significant decrease in lipoprotein(a) levels after treatment. However, they also observed a concerning decline in endothelial function in a substantial portion of the participants.
Potential Negative Effects of Niacin/Laropiprant on Endothelial Function
The results of this study raise a thought-provoking question: could the addition of laropiprant to niacin contribute to the observed negative effects on endothelial function? This observation aligns with the findings of the HPS2-THRIVE study, which also hinted at a lack of clinical benefit from niacin/laropiprant. The study's findings underscore the need for further exploration of the potential side effects associated with this treatment approach, particularly regarding its impact on vascular health.
Implications for Cardiovascular Health
The study highlights the crucial importance of understanding the multifaceted effects of medications on the cardiovascular system. While niacin/laropiprant shows promise in reducing lipoprotein(a) levels, its potential impact on endothelial function warrants further investigation. This research serves as a reminder that even seemingly beneficial interventions can carry unintended consequences, emphasizing the need for careful monitoring and personalized approaches to cardiovascular care.
Dr. Camel's Conclusion
Just like the camel navigates the vast desert with careful planning and caution, we must approach cardiovascular health with a similar approach. This study reminds us that the road to good health is often filled with unexpected turns and that careful consideration must be given to potential side effects. While niacin/laropiprant may be beneficial for some, its potential impact on vascular health warrants further exploration.
Date :
- Date Completed 2016-12-13
- Date Revised 2018-11-13
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.